Real-world data now suggest that GLP-1s may reduce HS morbidity
However, it is not the target maintenance dose
An experimental GLP-1 pill helped people with obesity lose a significant amount of weight in a late-stage clinical trial, which suggests people who fear needles might soon have a way to take these medicines without the need for injections
In the context of "healthy aging," glutathione helps protect the mitochondriathe powerhouses of your cells
Vitamin E : protects cell membranes, improves hydration
Ozempic Re-Titration After Stopping: How to Safely Restart Semaglutide At a glance Starting re-titration dose / 0.25 mg subcutaneous once weekly Minimum time at 0.25 mg before advancing / 4 weeks Standard step to 0.5 mg / after 4 weeks at 0.25 mg Next available doses / 1.0 mg, then 1.7 mg, then 2.0 mg Minimum weeks per dose step (tolerability permitting) / 4 weeks Gap that triggers mandatory re-titration / more than 5 weeks since last dose Primary GI risk if steps are skipped / nausea and vomiting in up to 44% of patients Half-life of semaglutide / approximately 7 days (one week) Approved indications for Ozempic / type 2 diabetes (also cardiovascular risk reduction in T2D) Key trial supporting dose escalation design / SUSTAIN-7 (N=1,201) Why Re-Titration Is Necessary After Stopping Ozempic When you stop Ozempic, semaglutide's GLP-1 receptor agonism fades within 5 to 7 half-lives, roughly 5 to 7 weeks